secwatch.observer — SEC 8-K summary
======================================

Issuer:     Akouos, Inc. (—)
CIK:        0001722271
Form:       8-K
Filed at:   2022-12-01T23:59:59+00:00
Accession:  0001193125-22-296537
Event type: m_and_a
Sentiment:  positive
Materiality: 1.00
Item codes: 1.02, 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lilly completes acquisition of Akouos for $12.50/share + CVR; AKUS to be delisted
--------------------------------------------------------------------------------

- 81.1% of shares (29,992,668) validly tendered; Minimum Tender Condition satisfied.
- Stockholders receive $12.50 cash per share plus one CVR worth up to $3.00 per share.
- Merger effective Dec 1, 2022; Akouos now a wholly-owned subsidiary of Eli Lilly.
- Pre-merger board (Mathers, Parmar, Preston, et al.) resigned; new directors appointed.
- Common stock trading suspended on Nasdaq; company will file Form 25 to delist and deregister.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1722271/000119312522296537/0001193125-22-296537-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1722271/000119312522296537/d431190d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-296537

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer